Stroke of Genius: Key Updates in the 2026 Acute Ischemic Stroke Guidelines
This continuing education presentation will address the important updates in the 2026 AHA/ASA Guideline for Early Management of Patients with Acute Ischemic Stroke. The presentation will highlight how these recommendations differ from the prior 2018 guidelines to ensure that the audience is aware of current best practices for this disease state.
Target Audience
Pharmacist
Learning Objectives
At the conclusion of the activity, participants should be able to:
1. Describe key updates in the 2026 AHA/ASA clinical practice guidelines
2. Compare new recommendations with the previous guideline standards for pharmacotherapy options, including thrombolytic and antithrombotic therapies
3. Apply updated guideline recommendations to clinical scenarios to optimize pharmacotherapy and improve patient outcomes
Additional Information
| Attachment | Size |
|---|---|
| 337.68 KB | |
| 99.5 KB |
This continuing education presentation will address the important updates in the 2026 AHA/ASA Guideline for Early Management of Patients with Acute Ischemic Stroke. The presentation will highlight how these recommendations differ from the prior 2018 guidelines to ensure that the audience is aware of current best practices for this disease state.
Rylan Sergi

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 0.5 contact hours of continuing pharmacy education credit.
Available Credit
- 0.50 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.

Facebook
X
LinkedIn
Forward